KPMA to enforce fair competition code for pharmaceutical firms

The Korea Pharmaceutical Manufacturers Association held an explanatory session towards the revised fair trade code on March 25, noting that if those firms, which were subject to the first collective order on the ground of violating the first fair competition code, are found to hold a product-related explanatory session, seminar and symposium in foreign countries, the KPMA will immediately issue...